
President Trump’s executive order ending taxpayer-funded gender transition surgeries in federal prisons overturns a controversial precedent that forced Americans to bankroll intimate medical procedures for convicted criminals—a move reflecting the clear will of voters who rejected such policies at the ballot box.
Story Highlights
- Trump’s January 2025 executive order halted federal funding for gender-affirming surgeries and hormone therapy in prisons, reversing a 2022 landmark settlement
- Only two federal inmates received taxpayer-funded gender transition surgeries before the policy reversal, despite the Bureau of Prisons spending $153,000 on hormone treatments in fiscal year 2022
- New Bureau of Prisons guidelines prohibit housing biological males in women’s facilities and require the use of sex-based pronouns, protecting female inmates
- The policy aligns with 55% of voters who viewed excessive support for transgender rights as problematic in the 2024 election
- ACLU filed a lawsuit challenging the order, while the White House defends the policy as common-sense protection for women and fiscal responsibility
Trump Restores Common Sense to Prison Healthcare
President Trump issued an executive order on January 20, 2025, immediately upon taking office, that prohibited federal funding for gender-affirming care in prisons and immigration detention facilities.
The order mandates the separation of biological males from women’s facilities and ends taxpayer funding for transition-related medical procedures.
The Bureau of Prisons responded in February 2026 with comprehensive guidelines that halt new surgery referrals, ban gender-aligned clothing distribution, and require staff to use pronouns matching inmates’ biological sex. This decisive action fulfills a campaign promise to restore fiscal sanity and protect women’s spaces from government-mandated ideology.
Landmark Case That Opened Floodgates Now Reversed
Cristina Iglesias, a transgender inmate, filed a handwritten lawsuit in 2019 demanding gender transition surgery while incarcerated. After years of litigation, Iglesias secured a 2022 settlement with the Bureau of Prisons recognizing such surgeries as medically necessary—the first publicly documented case in federal custody.
The settlement transferred Iglesias to a women’s prison in 2021 and resulted in surgery for two federal inmates in total. Prior to 2022, zero federal prisoners had received taxpayer-funded gender transition surgeries, unlike some states, where California alone performed 20 such procedures.
This precedent threatened to expand dramatically, forcing taxpayers to fund intimate elective procedures for convicted criminals serving time for breaking the law.
Minimal Costs Still Represent Misplaced Priorities
The Bureau of Prisons spent $153,000 on hormone treatments in fiscal year 2022, representing just 0.01% of the agency’s health spending for approximately 1,200 transgender inmates among 1.25 million total prisoners nationwide.
While advocates argue these costs are negligible, the principle matters more than the dollar amount. American taxpayers should not be compelled to fund controversial medical procedures for incarcerated criminals when law-abiding citizens struggle to afford their own healthcare.
The White House spokesperson, Anna Kelly, defended the policy by rejecting what she called the “insanity” of forcing taxpayers to pay for prisoner transitions, emphasizing that elections have consequences and that voters clearly rejected such programs at the ballot box.
Trump Halts Taxpayer-Funded Trans Surgeries in Federal Prisons #CommonSensePrevails https://t.co/r5BtbXPS6B
— Common Sense Isn’t Common (@KibblesNBits) March 3, 2026
Safety Concerns and Constitutional Protections Collide
The new Bureau of Prisons guidelines prohibit housing biological males in women’s facilities, reversing transfers that placed transgender inmates like Iglesias in female prisons.
Advocates claim this creates safety risks for transgender inmates in men’s facilities. However, the policy prioritizes protection for female inmates who should not be housed with biological males regardless of gender identity. The ACLU filed a lawsuit on March 7, 2025, alleging the policy violates constitutional protections and harms transgender prisoners.
However, the administration maintains that protecting women’s spaces and ending taxpayer funding for elective procedures represents common-sense governance. The clash highlights fundamental disagreements about whether gender dysphoria treatments constitute medically necessary care or ideologically driven social engineering that taxpayers should not subsidize for criminals.
Voter Mandate Drives Policy Reversal
The November 5, 2024, election provided clear evidence that Americans rejected excessive accommodation of transgender ideology, with 55% of voters viewing support for transgender rights as going too far, according to VoteCast polling. This voter sentiment directly influenced Trump’s swift action upon taking office.
The policy represents a fulfillment of campaign promises to restore traditional values and end woke government programs that offend common sense and fiscal responsibility.
While approximately 1,200 transgender federal inmates face changes to their care protocols, the policy establishes clear boundaries that prioritize biological reality over subjective identity claims, protecting women’s facilities and taxpayer dollars from further abuse under the guise of medical necessity.
Sources:
Her Case Changed Trans Care in Prison. Now Trump Aims To Reverse It – KFF Health News
How Trump’s executive order reversed a landmark transgender care case – The 19th
Congressional Hearing Document on Federal Bureau of Prisons












